Candriam SCA’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
312,452
+20,983
| +7% | +$1.33M | 0.11% | 168 |
|
|
2025
Q1 | $15.4M | Sell |
291,469
-40,923
| -12% | -$2.17M | 0.1% | 191 |
|
|
2024
Q4 | $18.6M | Sell |
332,392
-62,985
| -16% | -$3.53M | 0.11% | 174 |
|
|
2024
Q3 | $20.7M | Buy |
395,377
+123,979
| +46% | +$6.49M | 0.12% | 176 |
|
|
2024
Q2 | $11.1M | Buy |
+271,398
| New | +$11.1M | 0.07% | 242 |
|
|
2023
Q1 | – | Sell |
-32,479
| Closed | -$946K | – | 920 |
|
|
2022
Q4 | $946K | Sell |
32,479
-5,755
| -15% | -$168K | 0.01% | 702 |
|
|
2022
Q3 | $937K | Buy |
+38,234
| New | +$937K | 0.01% | 723 |
|